These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15620146)

  • 61. Distribution and activity levels of matrix metalloproteinase 2 and 9 in canine and feline osteosarcoma.
    Gebhard C; Fuchs-Baumgartinger A; Razzazi-Fazeli E; Miller I; Walter I
    Can J Vet Res; 2016 Jan; 80(1):66-73. PubMed ID: 26733734
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Significance of MMP2 and MMP9 expression in prostate cancer].
    Zhang XY; Hong BF; Chen GF; Lu YL; Zhong M
    Zhonghua Nan Ke Xue; 2005 May; 11(5):359-61, 364. PubMed ID: 15934460
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Expression of epidermal growth factor receptor Ki67 and p16 in human middle ear cholesteatoma].
    Li S; Zhan H; Peng S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Nov; 22(21):987-91. PubMed ID: 19157151
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gelatinase expression and proteolytic activity in giant-cell arteritis.
    Segarra M; García-Martínez A; Sánchez M; Hernández-Rodríguez J; Lozano E; Grau JM; Cid MC
    Ann Rheum Dis; 2007 Nov; 66(11):1429-35. PubMed ID: 17502363
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A comparison of patterns of disease extension in keratosis obturans and external auditory canal cholesteatoma.
    Shinnabe A; Hara M; Hasegawa M; Matsuzawa S; Kanazawa H; Yoshida N; Iino Y
    Otol Neurotol; 2013 Jan; 34(1):91-4. PubMed ID: 23235551
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Involvement of interleukin-1 in middle ear cholesteatoma.
    Shiwa M; Kojima H; Kamide Y; Moriyama H
    Am J Otolaryngol; 1995; 16(5):319-24. PubMed ID: 7503375
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin.
    Sudhoff H; Bujía J; Fisseler-Eckhoff A; Holly A; Schulz-Flake C; Hildmann H
    Laryngoscope; 1995 Nov; 105(11):1227-31. PubMed ID: 7475881
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Variation in expression and activity pattern of mmp2 and mmp9 on different time scales in the regenerating caudal fin of Poecilia latipinna.
    Murawala H; Patel S; Ranadive I; Desai I; Balakrishnan S
    J Fish Biol; 2018 May; 92(5):1604-1619. PubMed ID: 29633266
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression of telomerase activity in cholesteatoma otitis media.
    Goh EK; Lee BJ; Wang SG; Chon KM; Kim CM
    J Laryngol Otol; 2001 Nov; 115(11):881-4. PubMed ID: 11779302
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of disintegrin and metalloproteinase family proteins 10, 12 and 17 in cholesteatoma.
    Erbek S; Erinanc H; Hizal E; Ozluoglu LN
    J Laryngol Otol; 2013 Feb; 127(2):153-8. PubMed ID: 23318052
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [DNA character of the cholesteatoma].
    Cui Y; Pan H; Gao Q
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):62-3. PubMed ID: 12541864
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analysis of KRT1, KRT10, KRT19, TP53 and MMP9 expression in pediatric and adult cholesteatoma.
    Palkó E; Póliska S; Sziklai I; Penyige A
    PLoS One; 2018; 13(7):e0200840. PubMed ID: 30021014
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cell proliferation and apoptosis in human middle ear cholesteatoma.
    Kojima H; Tanaka Y; Tanaka T; Miyazaki H; Shiwa M; Kamide Y; Moriyama H
    Arch Otolaryngol Head Neck Surg; 1998 Mar; 124(3):261-4. PubMed ID: 9525508
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Apoptosis in meatal skin, cholesteatoma and squamous cell carcinoma of the ear.
    Ergün S; Carlsöö B; Zheng X
    Clin Otolaryngol Allied Sci; 1999 Aug; 24(4):280-5. PubMed ID: 10472461
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expression of MMP-14 and its role in bone destruction in middle ear cholesteatoma: A prospective observational study.
    Lei Y; An J; Ren Q; Wang M; Gao M
    Medicine (Baltimore); 2023 Oct; 102(43):e35538. PubMed ID: 37904429
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 44-plex cytokine profile of cholesteatoma.
    Britze A; Palmfeldt J; Gregersen N; Ovesen T
    Acta Otolaryngol; 2014 Jan; 134(1):41-50. PubMed ID: 24256045
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association of Matrix Metalloproteinase-2 mRNA Expression with Subtypes of Pediatric Cholesteatoma.
    Kan T; Ueda H; Takahara T; Tsuchiya Y; Kishimoto M; Uchida Y; Ogawa T; Ohashi W; Tsuzuki T; Fujimoto Y
    Biomed Res Int; 2021; 2021():6644897. PubMed ID: 33778077
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Circulating MMP2 and MMP9 in breast cancer -- potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories.
    Somiari SB; Somiari RI; Heckman CM; Olsen CH; Jordan RM; Russell SJ; Shriver CD
    Int J Cancer; 2006 Sep; 119(6):1403-11. PubMed ID: 16615109
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Collagenase activity in cholesteatoma.
    Iwanaga M; Yamamoto E
    ORL J Otorhinolaryngol Relat Spec; 1983; 45(3):166-75. PubMed ID: 6304590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.